Tirofiban for late window stroke due to artery plaque
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a drug called tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It is for strokes caused by a buildup of plaque in a large brain artery, and uses a special MRI to confirm the cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your stroke happened more than 24 hours ago but within the last 7 days
- A special MRI shows your stroke is from plaque buildup in a large artery in the front of your brain
- You have not had any bleeding in the brain
- Your stroke symptoms are moderate (score 4-20 on a stroke severity test)
- You do not have atrial fibrillation or a heart valve that needs blood thinners
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a clot-preventing medication called tirofiban before a mechanical clot removal procedure can improve recovery in people with a certain type of stroke. It's for those with a large artery blockage in the front part of the brain who are able to start the procedure within 12 hours.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial tests whether giving a medication called tirofiban directly into the artery (intra-arterially) after a successful clot removal can improve recovery after a stroke. Tirofiban helps prevent new clots from forming, which may reduce the chance of another stroke.
This trial tests a medication called tirofiban, which helps prevent blood clots, given after a successful procedure to remove a clot from a large brain artery. The goal is to see if it can reduce disability after a stroke when given within 24 hours of symptom onset.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.